Back to Search
CHUNG VU, MD
MD
Internal Medicine Physician
NPI: 1013905017Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators.
PMID 19199480·J Med Chem·2009
7-preclinical
Discovery of benzothiazole derivatives as efficacious and enterocyte-specific MTP inhibitors.
PMID 19181526·Bioorg Med Chem Lett·2009
4-observational
Tricyclic imidazoline derivatives as potent and selective adenosine A1 receptor antagonists.
PMID 17125265·J Med Chem·2006
7-preclinical
Recent advances in the design and optimization of adenosine A2A receptor antagonists.
PMID 16022182·Curr Opin Drug Discov Devel·2005
6-review
Synthesis of a 2'-deoxyguanosine adduct of cis-2-butene-1,4-dial, a reactive metabolite of furan.
PMID 15962936·Chem Res Toxicol·2005
8-other
Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
PMID 15771443·J Med Chem·2005
7-preclinical
Studies on adenosine A2a receptor antagonists: comparison of three core heterocycles.
PMID 15341933·Bioorg Med Chem Lett·2004
4-observational
Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonists.
PMID 15341934·Bioorg Med Chem Lett·2004
7-preclinical
Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
PMID 15294001·J Med Chem·2004
7-preclinical
Bone-targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agents.
PMID 12941336·Bioorg Med Chem Lett·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2593 S KING RD, #15
SAN JOSE, CA 95122 - Phone
- (408) 274-0226
Quick Facts
- NPI
- 1013905017
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile